As we all come to terms with the extraordinary and rapidly changing global situation caused by Covid-19, I would like to update you on the plans we have in…
Read update 22nd May, 2019Antibacterial resistance is an ever-increasing concern for today’s society. As more bacterial strains become resistant to greater numbers of antibiotics, we could see modern-day healthcare rewind back to the…
Read update 24th April, 2019A passionate, rigorous and dedicated team of scientists who deliver the highest quality services and products. Your reliable and knowledgeable partner.
Read update 24th April, 2019Learning from structures in the body, we recreate functional 3D in vitro models through innovation and science. Our models incorporate the “best biology” and are predictive of new drugs’…
Read update 24th April, 2019Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. We engineer…
Read update 24th April, 2019Our purpose is to bridge the gap between scientific discovery and patients. We make a difference by providing better predictions of clinical outcomes.
Read update 20th December, 20182018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team. Here are some of…
Read update 19th November, 2018International Trade Mission
Read update 9th November, 2018Congress Round-Up The International Congress on In Vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018. This year marks its 20th meeting, with the general theme of new…
Read update 11th July, 2018The meeting brings together individuals who are working on drug/xenobiotic research across a diverse range of fields such as clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal…
Read update 4th July, 2018Founded on the technology of Prof Lyle Armstrong and Prof Majlinda Lako from Newcastle University, the company is at the forefront of the production and differentiation of human induced…
Read update 22nd June, 2018To watch the full video click here.
Read update